000 01155 a2200325 4500
005 20250517085633.0
264 0 _c20161013
008 201610s 0 0 eng d
022 _a2044-5385
024 7 _a10.1038/bcj.2016.20
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLam, K
245 0 0 _aLoss of RUNX1 function results in enhanced granulocyte-colony-stimulating factor-mediated mobilization.
_h[electronic resource]
260 _bBlood cancer journal
_cMar 2016
300 _ae407 p.
_bdigital
500 _aPublication Type: Letter; Research Support, N.I.H., Extramural
650 0 4 _aCore Binding Factor Alpha 2 Subunit
_xdeficiency
650 0 4 _aDrug Resistance
650 0 4 _aGranulocyte Colony-Stimulating Factor
_xpharmacology
650 0 4 _aHematopoietic Stem Cell Mobilization
650 0 4 _aHematopoietic Stem Cells
_xdrug effects
650 0 4 _aHumans
700 1 _aMuselman, A
700 1 _aDu, R
700 1 _aYan, M
700 1 _aMatsuura, S
700 1 _aZhang, D-E
773 0 _tBlood cancer journal
_gvol. 6
_gp. e407
856 4 0 _uhttps://doi.org/10.1038/bcj.2016.20
_zAvailable from publisher's website
999 _c25864413
_d25864413